Characterization of a novel anti-DR5 monoclonal antibody WD1 with the potential to induce tumor cell apoptosis

Cellular and Molecular Immunology

Volumn 5, Issue 1, 2008, Pages 55-60

  Wang, Jing ^a,b   Lin, Zhou ^b   Qiao, Chunxia ^b   Lv, Ming ^b   Yu, Ming ^b   Xiao, He ^b   Wang, Qingyang ^b   Wang, Liyan ^b   Feng, Jiannan ^b   Shen, Beifen ^a,b   Ma, Yangfang ^a   Li, Yan ^a,b  

^a HENAN UNIVERSITY   (China)

^b INSTITUTE OF BASIC MEDICAL SCIENCES   (China)

Author keywords

apoptosis; ATPLite; death receptor 5; monoclonal antibody; TRAIL

Indexed keywords

MONOCLONAL ANTIBODY; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND RECEPTOR;

ANIMAL; APOPTOSIS; ARTICLE; BAGG ALBINO MOUSE; HUMAN; IMMUNOLOGY; ISOLATION AND PURIFICATION; LEUKEMIA CELL LINE; METABOLISM; MOUSE; TUMOR CELL LINE;

ANIMALS; ANTIBODIES, MONOCLONAL; APOPTOSIS; CELL LINE, TUMOR; HUMANS; JURKAT CELLS; MICE; MICE, INBRED BALB C; RECEPTORS, TNF-RELATED APOPTOSIS-INDUCING LIGAND; TNF-RELATED APOPTOSIS-INDUCING LIGAND;

EID: 47049106621     PISSN: 16727681     EISSN: None     Source Type: Journal    
DOI: 10.1038/cmi.2008.7     Document Type: Article

References (16)

1. Almasan A, Ashkenazi A. Apo2L/TRAIL: apoptosis signaling, biology, and potential for cancer therapy. Cytokine Growth Factor Rev. 2003;14:337-348. (Pubitemid 36693152)
2. Mérino D, Lalaoui N, Morizot A, et al. Differential inhibition of TRAIL-mediated DR5-DISC formation by decoy receptors 1 and 2. Mol Cell Biol. 2006;26:7046-7055. (Pubitemid 44477684)
3. Varfolomeev E, Maecker H, Sharp D, et al. Molecular determinants of kinase pathway activation by Apo2 ligand/ tumor necrosis factor-related apoptosis-inducing ligand. J Biol Chem. 2005;280:40599-40608. (Pubitemid 41780550)
4. Kischkel FC, Lawrence DA, Chuntharapai A, et al. Apo2L/ TRAIL-dependent recruitment of endogenous FADD and caspase-8 to death receptors 4 and 5. Immunity. 2000;12:611-620.
5. Griffith TS, Lynch DH. TRAIL: a molecule with multiple receptors and control mechanisms. Curr Opin immunol. 1998;10: 559-563. (Pubitemid 28479189)
6. Jo M, Kim TH, Seol DW, et al. Apoptosis induced in normal human hepatocytes by tumor necrosis factor-related apoptosisinducing ligand. Nat Med. 2000;6:564-567. (Pubitemid 30305907)
7. Chen JG, Wang YG, Zhao KP, et al. Gene expression and primary functional characterization of human DR5 extracellular fragment. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2007;23: 791-793.
8. Ma YF, Yang DL, Chen YH. Analysis of TRAIL receptor expression using anti-TRAIL death receptor-5 monoclonal antibodies. Chin Med J. 2003;116:947-950.
9. Qin W, Feng J, Zhang W, Li Y, Shen B. A novel TNF-α antagonizing peptide-Fc fusion protein designed based on CDRs of TNF-α neutralizing monoclonal antibody. Biochem Biophys Res Commun. 2004;322:1024-1028. (Pubitemid 39164456)
10. Roberta DP, Paola S, Rosalba R, et al. Ionizing radiation sensitizes erythroleukemic cells but not normal erythroblasts to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-mediated cytotoxicity by selective up-regulation of TRAIL-R1. Blood. 2001;1:2695-2603.
11. Chuntharapai A, Dodge K, Grimmer K, et al. Isotype-dependent inhibition of tumor growth in vivo by monoclonal antibodies to death receptor 4. J Immunol. 2001;166:4891-4898. (Pubitemid 32280698)
12. Walczak H, Miller RE, Ariail K, et al. Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo. Nat Med. 1999;5:157-163. (Pubitemid 29068521)
13. Buchsbaum DJ, Oliver PG, Zhou T, et al. Treatment with mTRA-8 anti-DR5 monoclonal antibody with or without chemotherapy inhibits human colon cancer xenograft growth in athymic nude mice. Proc Am Assoc Cancer Res. 2003;44:R753.
14. Chuntharapai A, Dodge K, Grimmer K, et al. Isotype-dependent inhibition of tumor growth in vivo by monoclonal antibodies to death receptor 4. J Immunol. 2001;166:4891-4898. (Pubitemid 32280698)
15. Cartron G, Dacheux L, Salles G, et al. Therapeutic activity of humanized anti-CD20 monoclonal antibody and polymorphism in IgG Fc receptor FcγRIIIa gene. Blood. 2002;99:754-758. (Pubitemid 34525533)
16. Dale LL, Daniel SP, Zhenping Z, Daniel JH, Peter B. Monoclonal antibody therpeutics and apoptosis. Oncogene. 2003;22:9097-9106.